Virtu KCG Holdings’s Catalyst Pharmaceutical CPRX Stock Holding History

Virtu KCG Holdings’s Portfolio CPRX Stock Details CPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$237K	Buy	+85,907	New	+$179K	0.01%	1963
2017 Q1	–	Sell	-54,200	Closed	-$57K	–	3199
2016 Q4	$57K	Buy	+54,200	New	+$61.9K	﹤0.01%	3061
2016 Q3	–	Sell	-12,865	Closed	-$9K	–	3107
2016 Q2	$9K	Buy	12,865 +2,719	+27%	+$2.19K	﹤0.01%	2854
2016 Q1	$12K	Sell	10,146 -17,414	-63%	-$27K	﹤0.01%	2637
2015 Q4	$68K	Sell	27,560 -23,240	-46%	-$66.6K	﹤0.01%	3092
2015 Q3	$152K	Buy	50,800 +30,265	+147%	+$131K	﹤0.01%	2689
2015 Q2	$85K	Buy	+20,535	New	+$81.8K	﹤0.01%	2954
2013 Q4	–	Sell	-31,287	Closed	-$95K	–	3833
2013 Q3	$95K	Buy	+31,287	New	+$52.6K	﹤0.01%	3380

Other funds holding CPRX

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Virtu KCG Holdings's CPRX Position: Q2 2017 in Review

Virtu KCG Holdings opened a new position in Catalyst Pharmaceutical (CPRX) in Q2 2017: 85,907 shares worth $237K. The stake represents 0.01% of the portfolio and ranks #1963 among its holdings. This is a return to the name: Virtu KCG Holdings previously reported a position in CPRX as recently as Q4 2016.

Virtu KCG Holdings first reported a position in CPRX in Q3 2013 and has held it in 8 quarters since. 69 funds tracked by Wall St. Rank hold CPRX as of Q2 2017.

Virtu KCG Holdings held 85,907 shares of Catalyst Pharmaceutical worth $237K as of Q2 2017.
Catalyst Pharmaceutical was a new Virtu KCG Holdings position in Q2 2017.
Catalyst Pharmaceutical made up 0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #1963 holding.
Virtu KCG Holdings first reported a position in Catalyst Pharmaceutical in Q3 2013 and has held it in 8 quarters since.
69 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.